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TBackground: The use of small-bore wire-guided chest drains for pleural effusions and pneumothorax has
become popular; however, limited data are available on its efficacy and morbidity. The aim of this retrospective
study is to measure, via the analysis of the so far largest reported cohort, the efficacy, safety, and tolerability of
this approach in different clinical conditions.
Methods: In the period from January 2002 to December 2008, 1092 patients have undergone the positioning of
a small-bore wire-guided chest drain (12F) for the evidence of pneumothorax or pleural effusion and have been
monitored over time for morbidity, pain at the time of insertion (measured via the visual analogue scale), and
drain failure for misplacement or blockage. Patients with trauma were excluded from this study.
Results:Male/female ratio and mean age were respectively 418:674 and 55.85  18.6. Three-hundred ninety-
nine (36.5%) drains were inserted for pneumothorax, 324 (29.7%) for malignant effusion, 97 (8.9%) for em-
pyema, and 272 (24.9%) for nonmalignant effusion. The pain experience was on average ‘‘very mild’’ (mean
visual analogue scale ¼ 4.6 mm). The overall drain failure rate was 12.9%. The percentage of successful cases
was 93.8% in malignant effusion, 93% in pneumothorax, and 92.3% in nonmalignant effusion; in the cases of
pathologically diagnosed empyema, drains were more likely to get blocked (74.2%). We recorded 1 serious
complication within the malignant effusion group.
Conclusions:Wire-guided 12FSeldinger-type drains are awell-tolerated and effectivemethod of treating pneumo-
thoraxanduncomplicatedpleural effusions (malignant andnonmalignant)with acceptablemorbidity.Theuseof12F
small-bore chest drain is not indicated for the treatment of empyema. (J Thorac Cardiovasc Surg 2011;141:683-7)The most appropriate size of the chest tube for drainage of
pneumothorax (PNX), pleural effusion, and empyema is
still a forum of open discussion among thoracic surgeons
and pneumologists. In fact, although positioning of the
small-bore wire-guided chest drain is definitely less trau-
matic and less uncomfortable for the patients than that of
the large-bore type, the effectiveness of these drains in pleu-
ral effusion and in empyema has not yet been validated in
sufficiently large clinical series.
To the best of our knowledge, and as recently reviewed by
the British Thoracic Society,1,2 there are only few studies
reporting relatively large series.3,4 Our everyday clinical
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The Journal of Thoracic and Caof the use of small-bore wire-guided chest drains, which
we have routinely been using over the past 10 years for
the treatment of nonmalignant and malignant pleural effu-
sions (NME/ME) and PNX. Aware of the limits of a retro-
spective analysis, however, we think that our findings
stemming from the investigation of the evidence on a large
cohort can importantly contribute to the discussion on the
indication for small-bore chest drain insertion and provide
definitive figures to exclude patients with pleural empyema
from this procedure.METHODS AND PATIENTS
This retrospective observational study involved 1092 patients with clin-
ical and radiologic evidence of PNX or ME/NME consecutively treated
with drainage via a small-borewire-guided drain in a period of 7 years (Jan-
uary 2002 toDecember 2008). Our selection policywas to treat each patient
who had PNX, NME/ME, or empyema with a small-bore drain. A commu-
nication to the institutional review board was issued and a coherent written
informed consent was implemented and obtained from all patients before
each procedure. Patients who required surgical placement of a chest drain
for thoracic surgery, evidence of thoracic trauma (hemothorax), and empy-
ema were excluded from this approach. These were treated with the posi-
tioning of larger tubes (24F–32F, bore size requirements evaluated on
a case-by-case basis), with radiologic guidance of the tube insertion, or
with a videothoracoscopic surgical approach, where appropriate. The em-
pyema cases recorded in this study consist of subjects in whom therdiovascular Surgery c Volume 141, Number 3 683
TABLE 1. Baseline clinical features of patients with pleuropulmonary
diseases treated with small-bore drains
Age (mean years  SD) 56  18
Gender (n (%))
Men 418 (38.7%)
Women 674 (61.3%)
Malignant effusion (n (%))
Total 324 (29.9%)
Lung cancer 122 (37.7%)
Mesothelioma 37 (11.4%)
Genitourinarian tract neoplasm 96 (29.6%)
Hematologic neoplasm 27 (8.3%)
Gastroenteric neoplasm 32 (9.9%)
Other neoplasm 10 (3.1%)
Nonmalignant effusion (n (%))
Total 272 (24.9%)
Cirrhosis 64 (23.5%)
Heart failure 15 (5.5%)
Postoperative (abdominal surgery) 40 (14.7%)
Kidney disease 13 (4.8%)
Parapneumonic effusion 122 (44.9%)
Abbreviations and Acronyms
ME ¼ malignant pleural effusion
NME ¼ nonmalignant pleural effusion
PNX ¼ pneumothorax
VAS ¼ visual analogue scale
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Sdiagnosis of empyema was made pathologically with chemical analysis of
the fluid that was radiologically and optically ‘‘clear.’’ We do not routinely
indicate chest tube placement for clinically evident empyema, where video-
assisted surgery is performed as soon as possible after diagnosis.
In ME cases we have adopted the positioning of a small-bore wire-
guided chest drain as a first-instance treatment. We routinely perform
video-assisted procedures for pleurodesis in all recurrent cases.
Positioning Technique
A 12F small-bore multifenestrated wire-guided chest drain (Portex
Seldinger Chest Drainage Kit; Smiths Medical, St Paul, Minn) was placed
with the Seldinger technique in all cases at the patient’s bed.
Patients were positioned in supine anti-Trendelenburg recumbence.
Local anesthesia was provided using 100 to 200 mg of lidocaine (2%
solution) and the drain was placed through the midclavicular line in the
II–III intercostal space or on the IV, V, or VI intercostal space on the middle
lateral line through the ‘‘triangle of safety.’’
The chest drain was secured to the skin with a 1–0 or 0–0 silk suture.
The drainage was connected to a water seal system and aspiration was
used in case of PNX if clinically needed. Antibiotic prophylaxis (intrave-
nous amoxicillin–clavulanate 2.2 g or ceftriaxone 2.0 g in selected patients
with anaphylaxis history for penicillin) was administered to all patients
immediately before the procedure.
A chest x-ray film was taken after each procedure to visualize the cor-
rect positioning of the drain in the pleural cavity.
Through the visual analogue scale (VAS),5 each patient was asked to in-
dicate the pain experienced at the time of the drain insertion by marking
a straight line ranging from 0 mm (no pain at all) to 100 mm (worst pain
ever). Minor complications, major complications, and number of days of
the drain in situ have also been recorded. Drain flushing was performed
with 50 mL of saline solution in case blockage was suspected. The drain
was removed when the amount of daily fluid was lower than 100 mL for
NME/ME and when there was no evidence of air leak with a complete ex-
pansion of the lung without aspiration (maintained routinely for 3 days) in
PNX cases.
Major complications of chest tube placement were defined as follows:
organ penetration, heart and great vessel puncture, diaphragmatic perfora-
tion, intercostal vessel perforation, thoracic empyema, and any other com-
plication that could not be included in any one of the previous categories
but that caused prolonged hospitalization. Minor complications were
wound infection, hypotension, and cutaneous bleeding. The failure of the
drainage was evaluated with the presence of one of the following condi-
tions: (1) inadequacy of placement or displacement of a chest tube that re-
quired its removal and replacement; (2) persistent PNX or NME/ME owing
to blockage of drainage (despite drain flushing).Other 18 (6.6%)
Pneumothorax (n (%))
Total 399 (36.5%)
Primary 285 (71.4%)
Secondary 114 (28.6%)
Empyema (n (%))
Total 97 (8.9%)
SD, Standard deviation.Statistical Methodology
Overall descriptive statistics were evaluated for all clinical and place-
ment technique parameters. In particular, the absolute and relative fre-
quency distributions of drainage failure and of the occurrence of major
and minor complications at the time of the insertion itself were calculated.
Measures of centrality and dispersion of the intensity of pain experienced
by the patients and the number of days of drainagewere calculated for each684 The Journal of Thoracic and Cardiovascular Surgsubgroup of patients with different indications for drainage. The risk of
minor complications, of drainage failure, of prolonged stay of the drain
in situ, and the risk of experiencing some pain at the time of insertion of
the drain, associated to each indication for drainage, were evaluated by
the Pearson c2 statistics. The statistical software STATA/SE Release 10.0
(StataCorp LP, College Station, Tex) was used to perform all analyses.
The level of significance was set at .05.RESULTS
Of the 1092 recruited subjects, 36.5% (n ¼ 399) were
treated for PNX, 29.7% (n ¼ 324) for ME, 24.9%
(n ¼ 272) for NME, and 8.9% (n ¼ 97) for empyema. In
all of these cases the diagnosis of empyema was made path-
ologically via the determination of the pH of the drained
fluid that appeared clear at optical inspection.
Repeated drainage was performed in 69 patients and
a larger bore was used in 15 of them; the remaining patients
were treated with a surgical approach or with radiologic
(chest x-ray film) follow-up.
Descriptive statistics have been summarized in Table 1.
Findings from the Pearson test of association are summa-
rized in Table 2.Safety and Tolerability
Major complications requiring a surgical approach
(video-assisted thoracoscopy) occurred in only 1 patient
with ME and consisted in the accidental loss of the wireery c March 2011
TABLE 2. Primary clinical outcomes in the use of small-bore drains for the treatment of pleuro-pulmonary diseases
Pneumothorax Nonmalignant effusion Malignant effusion Empyema
(n ¼ 399; 36.5%) (n ¼ 272; 24.9%) (n ¼ 324; 29.7%) (n ¼ 97; 8.9%)
Drainage failures
n (%) 28 (7%) 21 (7.7%) 20 (6.2%) 72 (74.2%)
Relative risk of drainage failure (95% CI) 0.43* (0.29; 0.64) 0.53* (0.39; 0.82) 0.39* (0.25; 0.62) 10.70* (8.29; 13.83)
Minor complications
n (%) 18 (4.5%) 22 (8.1%) 13 (4%) 14 (14.4%)
Relative risk of minor complications (95% CI) 0.64 (0.38; 1.08) 1.47 (0.90; 2.41) 0.57 (0.32; 1.03) 2.71* (1.56; 4.70)
Duration of drainage
Mean days  SD 4.42  1.24 5.73  1.55 5.5  1.54 7.6  1.53
>6 days: n (%) 344 (86.2%) 143 (52.6%) 192 (59.3%) 5 (5.2%)
 6 days: n (%) 55 (13.8%) 129 (47.4%) 132 (40.7%) 92 (94.8%)
Relative risk of prolonged drainage (95% CI) 0.27* (0.21; 0.35) 1.39* (1.19; 1.63) 1.13 (0.96; 1.33) 2.99* (2.70; 3.31)
Pain experience
Mean mm  SD 6.07  11.45 4.87  10.29 3.06  8.6 3.25  8.39
No pain: n (%) 245 (61.4%) 158 (58.1%) 259 (79.9%) 68 (70.1%)
Mild pain: n (%) 65 (16.3%) 71 (26.1%) 28 (8.7%) 20 (20.6%)
More severe pain: n (%) 89 (22.3%); 43 (15.8%); 37 (11.4%); 9 (9.3%);
Relative risk of experiencing some pain (95% CI) 1.29* (1.09; 1.52) 1.39* (1.16; 1.65) 0.52* (0.41; 0.66) 0.89 (0.65; 1.23)
Relative and absolute frequencies, estimated relative risks and 95% confidence intervals from a cohort analysis. CI, Confidence intervals; SD, standard deviation. *Evidence for
a significant association (P<.01).
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Sguide into the pleural cavity at insertion. A radiogram is in-
cluded as evidence (Figure 1). No hemothorax was re-
ported, nor was abdominal/thoracic/mediastinal organ
perforation or infection after the drain insertion procedure.
Minor complications occurred in 67 (6.14%) patients. In
particular, 18 events (4.5%) occurred among those with
PNX, 22 (8.1%) among those with NME, 13 (4%) were re-
corded in the ME group, and, last, 14 (14.4%) cases with
empyemawere also observed. Evidence emerged for an asso-
ciation between the occurrence of minor complications and
empyema, for which a relative risk of 2.71, with a 95% con-FIGURE 1. Accidental loss of a wire guide (gray indicators) into the
pleural space.
The Journal of Thoracic and Cafidence interval ranging from 1.56 to 4.70, was estimated.
A list of all minor complications is provided in Table 3.
Pain Experience
With regard to the VAS scoring for pain at the time of in-
sertion of the drain, and independently from the indication
for the insertion, most patients experienced no pain
(66.9%) (Figure 2). Only 1 patient with NME (parapneu-
monic) assigned the maximum scoring to the VAS. In par-
ticular, the proportion of individuals who declared no pain
were 245 (61.4%) of those with PNX, 158 (58.1%) of those
with NME, 259 (79.9%) with ME, and 68 (70.1%) with
empyema. The proportion of patients who reported having
mild pain (VAS ¼ 5 mm) never raised above 26.1%.
Effectiveness
Failure of the drainage procedure was experienced by 141
(12.9%) individuals. The causes were dislodgment in 59
(41.6%) and blockage or failure of resolution in 82
(58.4% of total failures) (Table 4). When accidental removal
or dislodgement (documented by chest radiography) wasTABLE 3. Minor complications in patients with pleuro-pulmonary
diseases treated with small-bore drains
N (%)
Total 67
Cough 35 (52.2%)
Hypotension 13 (19.4%)
Local bleeding 10 (14.9%)
Wound infection 4 (6%)
Surgical emphysema 5 (7.5%)
rdiovascular Surgery c Volume 141, Number 3 685
No pain Worst pain of ever
Mean of all cases                    4,62 (± 19,19) 
  0                                                                                               100  
Pneumothorax 6,06 (± 11,44) 
Maligant Effusion                   3,05 (± 8,6)  
Non Malignant Effusion   4,87 (± 10,29) 
Empyema                          3,24 (± 8,38) 
FIGURE 2. Distribution of pain score from 0 mm (no pain) to 100 mm (worst pain ever).
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Sobserved, the chest drains were replaced if the amount of vis-
ible pleural fluid at chest radiography was clinically signifi-
cant. When blockage occurred, even after periodic flushing
with saline solution (n¼ 43), an attempt to reinsert the drain
was made. We therefore observed the presence of fibrin or
blood coagula into the drain in almost all these cases.
Effectiveness of drainage was found to be associated with
the indication for the procedure itself. In particular, a large
proportion of patients with empyema experienced a failure
with the small-bore drain. The absolute and relative fre-
quency of failures for PNX, for NME/ME, and for empyema
(pathologic) indications are reported in Table 4. From the
analysis of exposure to the 4 different indications for drain-
age, itwas estimated that patientswith empyema (pathologic)
were 10.7 times more at risk of experiencing a failure of the
drain procedure than patients with any of the other indica-
tions. It was further estimated, with a 95% confidence, that
this risk could be as low as 8.3 and as high as 13.8.Duration of Drainage
The observed mean duration of drainage was just under
4.5  1.25 days for the PNX group, about 5.5  1.25 days
for the ME group, 5.75  1.5 days for the NME group, and
just over 7.5  1.5 days for the empyema group. Moreover,
it was observed that patients naturally clustered into 2
groups: those who kept the drain in situ for no less than 6
days and those who kept it for 6 days or more (details in
Table 2). However, no patient with empyema kept the drain
in place for less than 5 days. From this study it was observed
that 86.7% (n¼ 344) of subjectswith PNX, 59.3% (n¼ 192)TABLE 4. Absolute and relative frequencies for drainage failures by
indication for drain insertion
Reason for drain removal
Blockage Dislodgment
Indication for drain insertion N (%) n (%) n (%)
Pneumothorax 28 (7) 2 (7) 26 (93)
Nonmalignant effusion 21 (7.7) 7 (33) 14 (67)
Malignant effusion 20 (6.2) 12 (60) 8 (40)
Empyema 72 (74.2) 61 (85) 11 (15)
Grand total 141 (12.9) 82 (58) 59 (42)
686 The Journal of Thoracic and Cardiovascular Surgof those with ME, and 52.6% (n ¼ 143) of those with NME
kept the drain in place for less than 5 days. Only 5.2% of pa-
tients with empyema had it for such a short period of time. It
was, in fact, estimated that the latter group had a risk for
a prolonged drainage 3 times higher than any of the other
3 subpopulations (95% confidence intervals: 2.70; 3.31).DISCUSSION
Even if the daily activity and the international guidelines
report a better tolerability and safety of small-bore wire-
guided chest drains in the treatment of NME/ME and
PNX, the effectiveness of this approach is still debated
and is not entirely evidence-based. In particular, the correct
indications for the use of this type of drain inserted via the
Seldinger technique are still a matter of discussion. In this
context, in 2008 Davies, Merchant, and McGown 4 drew
the attention of pneumologists and thoracic surgeons to
the lack of data from large-scale (randomized) clinical trials
that supported the choice of small-bore (12F) wire-guided
chest drains, instead of large-bore ones, for the treatment
of various pleuropulmonary conditions. Davies’ study, to-
gether with the publication of Horsley and associates,3 rep-
resents, to the best of our knowledge, the only report
addressing, with a retrospective analysis of prospectically
gathered data, the effectiveness and complication rates of
small-bore wire-guided chest drains inserted percutane-
ously via the Seldinger technique. A significant ethical situ-
ation arose since the small-bore chest drains have beenmade
available for clinical use. This is connected with the fact that
the 2 systems (small-bore versus large-bore drains) imply
a very different impact on the patients in terms of tolerabil-
ity, pain, and safety (and probably costs, given the fact that
lareg-bore drains are routinely positioned in surgical the-
aters, whereas small-bore wire-guided ones are placed at
the patient’s bedside). It is, thus, very difficult from the eth-
ical standpoint to properly design and run a prospective ran-
domized trial. Concerning safety, the life-threatening
complications of large-bore intercostal chest drains are
widely documented and described with rates of incidence
from 0.2% to 6%.2,6-8 The complications include organ
penetration leading to lung laceration, heart and greatery c March 2011
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Svessel puncture, diaphragmatic perforation, and spleen/liver
injury. According to the relevant available literature, the
frequency of these complications is notably reduced
thanks to the use of the small-bore drains.6 As well, other
complications like empyema, secondary to the insertion of
pleural catheters, vary widely, with rates of up to 25%.9,10
In the present study, there were no cases of empyema or
drain site infections, and we speculate that this may be
due to the definitely more rapid insertion of the small-bore
wire-guided drains and to the minimal disruption of the
chest wall as compared with blunt dissection. Antibiotic
prophylaxis is normally used in both types of procedures.
We registered 1 major complication only, the accidental
loss of the wire guide into the pleural cavity, and the rates
of minor complications in absolute terms were acceptable
if compared with the scarce data available in the literature.
With regard to pain and tolerability, the small-bore wire-
guided chest drains are generally considered more comfort-
able by the patients and induce less pain at the moment of
insertion and afterward, compared with the large-bore
ones.11 In line with the evidences reported by Horsley and
colleagues3 and Davies, Gleeson, and Davies, 1 our results
showed that, independently from the indication the inser-
tion, most of our patients had a significant absence of
pain at the time of drain insertion.
An interesting point of open discussion remains the effec-
tiveness of small-bore drains in PNX, NME/ME, and empy-
ema. Our findings are in line with those of Horsley and
colleagues,3 although they reported a higher rate of failure,
blockage, or displacement: 37% of the total procedures,
7.5% of which represented by chest drain obstructions.
Smaller figures were found in the article by Davies, Mer-
chant, and McGown,4 who reported a 9% of blockage,
a closer percentage to that observed in the present study
(12.9%). This dissimilarity stays dubious and probably is
due to the frequency of drain flushing in the different series.
Similarly, the draindisplacement ratewas reported in the lit-
eraturewith a high variability (ranging from6%–21%)3,4 and
in the present study occurred in the 5.4% of cases. The 21%
failure rate seems unacceptably high. We could infer that
this may be due to different stitching techniques. Methods
for securing chest drains vary between practitioners, and
although various techniques have been described for large-
bore drains,12 the chosen strategies often depend on peer
recommendation and local clinical practice rather than on
randomized trial data.
Our experience also confirms the lower effectiveness of
small-bore wire-guided drains at resolving empyema, with
a limited success rate (24%) and high propensity for block-
age. Although these findings are not surprising, Horsley and
associates3 also suggested that small-bore wire-guided
drains (<20F) should not be routinely used in the treatment
of empyema. This aspect is evident in the estimated number
of days of drain in situ, which was significantly longer forThe Journal of Thoracic and Capatients with empyema than for those with other conditions.
Finally, our results confirmed that the procedure-related
pain is very low, regardless of the indication.
Limitations
This series is numerous and homogeneous. However,
conclusions suffer from the fact that they are drawn on a ret-
rospective analysis of prospectically gathered data. This
should be kept in mind when revision of clinical procedures
or guidelines is considered, based on these study results. Of
course, there is an ethical problem in designing prospective
randomized trials, given the very significant differences al-
ready highlighted in the preliminary observational experi-
ences among the use of small- versus large- bore drains.
We have excluded trauma patients from this study. Still,
we consider this a significant limitation of our findings.
We advocate for further research in this category of patients
inasmuch as it would seem logical that in selected trauma
cases the adoption of small-bore wire-guided chest drains
may provide significant advantages (for example in the
case of rib fractures without hemothorax).
CONCLUSIONS
Our data support the evidence that the use of small-bore
wire-guided 12F chest drains inserted via the percutaneous
Seldinger technique is a safe and well-tolerated procedure,
particularly in PNX, ME, and NME. In pathologically diag-
nosed empyema, however, we observed a low success rate
and tendency to blockage, confirming the absence of indica-
tion for this condition. A larger base of evidence could be
obtained with randomized trials, but these may prove diffi-
cult to design for ethical reasons.References
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